Go to content
UR Home

Tamoxifen treatment for male breast cancer and risk of thromboembolism: prospective cohort analysis

Eggemann, Holm ; Bernreiter, Anna-Lena ; Reinisch, Mattea ; Loibl, Sibylle ; Taran, Florin-Andrei ; Costa, Serban-Dan ; Ignatov, Atanas


PURPOSE: Thromboembolism is a common adverse event in women treated with tamoxifen (TAM) for breast cancer. The risk in male breast cancer patients is poorly investigated. We aimed to examine the risk of thrombotic events after TAM in male breast cancer patients. PATIENTS AND METHODS: In this prospective cohort study, 448 patients treated between May 2009 and July 2017 for male breast cancer (BC) ...


Owner only: item control page
  1. Homepage UR

University Library

Publication Server


Publishing: oa@ur.de
0941 943 -4239 or -69394

Dissertations: dissertationen@ur.de
0941 943 -3904

Research data: datahub@ur.de
0941 943 -5707

Contact persons